These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32676266)

  • 21. The short-term efficacy of intravitreal ranibizumab, aflibercept and dexamethasone implant in the treatment of macular edema due to non-ischemic central retinal vein occlusion.
    Yucel OE; Birinci H; Sullu Y
    Int Ophthalmol; 2019 Apr; 39(4):891-901. PubMed ID: 29550932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
    Maggio E; Sartore M; Attanasio M; Maraone G; Guerriero M; Polito A; Pertile G
    Am J Ophthalmol; 2018 Nov; 195():209-222. PubMed ID: 30098350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-Term Outcomes of Refractory Diabetic Macular Edema Switch From Ranibizumab to Dexamethasone Implant and the Influential Factors: A Retrospective Real World Experience.
    Hsia NY; Lin CJ; Chen HS; Chang CH; Bair H; Lai CT; Lin JM; Chen WL; Tien PT; Wu WC; Tsai YY
    Front Med (Lausanne); 2021; 8():649979. PubMed ID: 33996856
    [No Abstract]   [Full Text] [Related]  

  • 24. Combined Intravitreal Dexamethasone Implant And Micropulse Yellow Laser For Treatment Of Anti-VEGF Resistant Diabetic Macular Edema.
    Elhamid AHA
    Open Ophthalmol J; 2017; 11():164-172. PubMed ID: 28839510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative Analysis of Intravitreal Dexamethasone Implant (Ozurdex) and Brolucizumab Injection in the Treatment of Diabetic Macular Edema with Hyperreflective Intraretinal Dots: A Retrospective Study.
    Chakraborty S; Sheth JU
    Clin Ophthalmol; 2024; 18():2897-2905. PubMed ID: 39429440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Ozurdex implant in recalcitrant diabetic macular edema--a single-center experience.
    Bansal P; Gupta V; Gupta A; Dogra MR; Ram J
    Int Ophthalmol; 2016 Apr; 36(2):207-16. PubMed ID: 26233578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of vitrectomy combined with an intraoperative dexamethasone implant in refractory diabetic macular edema.
    Jung YH; Lee Y
    Acta Diabetol; 2019 Jun; 56(6):691-696. PubMed ID: 30824977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema: real-world data versus clinical trials outcomes.
    Neves P; Ornelas M; Matias I; Rodrigues J; Santos M; Dutra-Medeiros M; Martins D
    Int J Ophthalmol; 2021; 14(10):1571-1580. PubMed ID: 34667735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: A Real-World Experience.
    Mello Filho P; Andrade G; Maia A; Maia M; Biccas Neto L; Muralha Neto A; Moura Brasil O; Minelli E; Dalloul C; Iglicki M
    Ophthalmologica; 2019; 241(1):9-16. PubMed ID: 30408801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Early efficacy of dexamethasone implant (OZURDEX
    Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
    J Fr Ophtalmol; 2017 May; 40(5):408-413. PubMed ID: 28336283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment.
    Rehak M; Busch C; Unterlauft JD; Jochmann C; Wiedemann P
    Acta Diabetol; 2020 Apr; 57(4):469-478. PubMed ID: 31749051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema.
    Klamann A; Böttcher K; Ackermann P; Geerling G; Schargus M; Guthoff R
    Ophthalmologica; 2016; 236(4):181-185. PubMed ID: 27915343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of intravitreal dexamethasone implant for the treatment of ranibizumab-resistant macular edema secondary to retinal vein occlusion.
    Manousaridis K; Peter S; Mennel S
    Int Ophthalmol; 2017 Feb; 37(1):47-53. PubMed ID: 27043320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion.
    Moon SY; Cho KH; Woo SJ; Park SP; Kim YK
    Korean J Ophthalmol; 2018 Feb; 32(1):29-37. PubMed ID: 29376223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid response to dexamethasone intravitreal implant in diabetic macular edema.
    Lo Giudice G; Avarello A; Campana G; Galan A
    Eur J Ophthalmol; 2018 Jan; 28(1):74-79. PubMed ID: 28708221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study.
    Lam WC; Albiani DA; Yoganathan P; Chen JC; Kherani A; Maberley DA; Oliver A; Rabinovitch T; Sheidow TG; Tourville E; Wittenberg LA; Sigouin C; Baptiste DC
    Clin Ophthalmol; 2015; 9():1255-68. PubMed ID: 26203215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema.
    Fouda SM; Bahgat AM
    Clin Ophthalmol; 2017; 11():567-571. PubMed ID: 28356711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal dexamethasone implant Ozurdex in the treatment of diabetic macular edema in patients not previously treated with any intravitreal drug: a prospective 12-month follow-up study.
    Menezo M; Roca M; Menezo V; Pascual I
    Curr Med Res Opin; 2019 Dec; 35(12):2111-2116. PubMed ID: 31378087
    [No Abstract]   [Full Text] [Related]  

  • 39. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexamethasone intravitreal implant in vitrectomized versus nonvitrectomized eyes for treatment of patients with persistent diabetic macular edema.
    Medeiros MD; Alkabes M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B
    J Ocul Pharmacol Ther; 2014 Nov; 30(9):709-16. PubMed ID: 25259834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.